TrialBMC cancer2013

Higher rate of skin rash in a phase II trial with weekly nanoparticle albumin-bound paclitaxel and cisplatin combination in Chinese breast cancer patients.

Li Chen Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.